NeuroScientific Biopharmaceuticals Health Care
Biotech Healthcare

$0.080 0.005 (6.67%)

High $0.08	Low $0.08	Trades 10	Turnover $19,245	Volume 244,049
30 June 2023 at 1:52pm

If you were already registered, log in here.

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code NSB	Name Neuroscientific Biopharmaceuticals Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Biotechnology	GIC Sub Industry Biotechnology
Sector Healthcare	IPO Date N/A	Fiscal Year June	Type Common Stock
Shares Outstanding 389,718,547	Shares Floated 152,641,063	Held by Insiders 45.211%	Held by Institutions 0%

Directors & Officers

Name & Education	Position
Mr. Nathan Smith	Chief Executive Officer
Dr. Marian Sturm	Chief Scientific Officer
Dr. Catherine Cole MBBS	Chief Medical Officer
Mr. Christopher Bryan James Achurch B.Com., C.A.	Company Secretary

NSB Historic Dividends

Date	Amount
We found no dividends on record for NSB.

If you were already registered, log in here.

End of Day Prices

Date	Close	Volume	Change
27-Oct	$0.05	209,535	+0.00 (3.85%)
26-Oct	$0.05	500,632	0.00 (7.14%)
23-Oct	$0.06	312,775	0.00 (3.45%)
22-Oct	$0.06	142,508	0.00 (3.33%)
21-Oct	$0.06	23,161	+0.00 (3.45%)
20-Oct	$0.06	152,001	0.00 (3.33%)
19-Oct	$0.06	22,223	0.00 (1.64%)
16-Oct	$0.06	1,950	0.00 (0.00%)
15-Oct	$0.06	53,245	+0.00 (8.93%)
14-Oct	$0.06	585,124	0.00 (5.08%)
13-Oct	$0.06	22,123	+0.00 (1.72%)
08-Oct	$0.06	23,000	0.00 (7.94%)
07-Oct	$0.06	26	+0.00 (1.61%)
06-Oct	$0.06	65,725	+0.00 (1.64%)
05-Oct	$0.06	127,970	+0.00 (5.17%)
7 up, 7 down, and 1 flat days

Market Cap (27-Oct) $21,044,802	EBITDA -	PE 0.00	Book Value $0.04
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.01	Profit Margin N/A
Operating Margin -3407.53%	ROA 18.3%	ROE 29.68%	Revenue (FY) $402,659
Revenue per Share $0.00	Gross Profit (FY) $258,277	Q' YOY Revenue Growth 87.6%	Q' YOY Earnings Growth 22.8%

NeuroScientific Biopharmaceuticals Health Care
Biotech Healthcare

Stock Information

Technicals

Financial Snapshot (June 2026)

Directors & Officers

NSB Historic Dividends

Followers

Prices

Announcements

End of Day Prices

NeuroScientific Biopharmaceuticals Health Care Biotech Healthcare

Stock Information

Technicals

Financial Snapshot (June 2026)

Directors & Officers

NSB Historic Dividends

Followers

Prices

Announcements

End of Day Prices

NeuroScientific Biopharmaceuticals Health Care
Biotech Healthcare